Late last week, Endo International plc ENDP announced that the company has decided to withdraw its supplemental new drug application (sNDA) related to specific abuse deterrent labeling for Opana ER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback